About the Journal
ISSN - 0973-0958
ISSN - 0973-0958
About the Journal
| Volume :
Patent Ductus Arteriosus in preterm infants: does it matter if we wait longer to treat?
Presented in National Medical Students Paediatric Conference (NMSPC) 2014, Brighton, UK
St Georges University, London, UK
Whether to close a patent ductus arteriosus (PDA) and the timing of treatment are common clinical dilemmas for clinicians looking after preterm infants. Many clinicians are less willing to treat and wait for the PDA to close. However, there is a concern that if treatment is required, infants are being treated later in postnatal life which may be less effective.
1.To evaluate the impact of timing of treatment on the need for ligation and associated outcomes.
2.To determine the impact of gestational age on need for ligation.
3.To compare outcomes of infants requiring ligation with those where PDA closed medically.
Data for 112 babies with treated PDAs between 2007-2013 were collected from the St George’s neonatal database for: intervention used to close the PDA and timing of the intervention. Outcome data was identified for duration of treatment, chronic lung disease (CLD), respiratory support at 36 weeks corrected gestation, home oxygen, mortality, intraventricular hemorrhage, necrotising enterocolitis, and retinopathy of prematurity.
The likelihood of requiring surgical ligation was higher than medical closure only for infants born at 23 weeks gestation. Of those who underwent ligation, a greater proportion were ventilated at 36 weeks (35% vs 4%, p<0.001) and discharged on home oxygen (62% vs. 28%, p =0.01). Although the likelihood of medical closure was higher when medication was commenced in the first 3 weeks of life, mortality rates were higher the earlier treatment was commenced (numbers however were low). There were no other significant associations found between the interventions, gestational age, clinical outcomes and treatment timing.
The results support the current concerns expressed in the neonatal medical literature that treatment does little to alter clinical outcomes except in very few selected cases. A symptomatic ‘wait and watch’ approach before offering treatment is warranted.
How to Cite URL :
Omr A..Available From : http://www.pediatriconcall.com/Journal/Article/FullText.aspx?artid=8801&type=C&tid=0&imgid=0&reportid=813&tbltype=
Find Articles in same issue
Find Articles under same category
What is the diagnosis_?
A 3 years old boy presented with persistent indirect jaundice since 1 month of life. At 4 months of age he was detected to have involuntary movements with developmental delay. MRI brain showed hypomyellination with hyper intensities in globus pallid...
What is the cause of indirect hyperbilirubinemia_?
App Store | Google Play
Reviewers & Experts Panel
Want to Become a Reviewer
Pediatric Oncall Home
Conferences & CME Center
Diseases & Conditions
Drugs & Poisoning Center
Question of the Day
Diet & Diseases
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
Don’t have an Account? Register Now!